These 5 Dividend Stocks Survived 2008, COVID and Every Recession Before Them
Chasing the fattest yield on the screen is a trap most income investors fall into, but a handful of companies have quietly raised their payouts through oil shocks, financial meltdowns, and a global pandemic without skipping a beat. The question…
Income investors often chase the fattest current yield on the screen. That is a mistake. A payout that has been raised straight through the 1990 recession, the dot-com bust, the 2008 financial crisis and the 2020 COVID shock tells you something a 6% yield cannot: management protected the cash return when earnings compressed, credit markets froze and consumers stopped spending. Below are five names whose raise streaks survived every US downturn on record, ranked by the length of that streak.
No. 5: PepsiCo, a 53-Year Streak Backed by Snacks and Beverages
PepsiCo (NASDAQ:PEP | PEP Price Prediction) has raised its dividend for 53+ consecutive years, spanning every US recession since 1972. The current quarterly payout is $1.48, up from $1.4225, and the dividend yield sits at 4.21%, the highest on this list. Q2 2026 revenue rose to $24.18B (+6.4% YoY) with core EPS of $2.20, and management plans ~$8.9B in total cash returns in 2026. The snack-plus-beverage model held up in past downturns because Lay’s, Doritos and Gatorade are cheap indulgences consumers keep buying.
No. 4: Colgate-Palmolive, 62 Years of Uninterrupted Increases
Colgate-Palmolive (NYSE:CL) has raised its dividend for 62 consecutive years, uninterrupted since 1963. The quarterly payout ticked up to $0.53 in 2026 from $0.52, with a yield of 2.37%. Q2 2026 base-business EPS of $0.99 beat the $0.95 estimate, the fifth straight beat, and gross margin expanded 140bps to 61.5%. Toothpaste, soap and pet food are recession classics: consumers keep brushing and feeding the dog when GDP contracts.
No. 3: Coca-Cola, a 63-Year Raise Streak With Global Reach
Coca-Cola (NYSE:KO) has lifted its payout for 63 consecutive years. The current quarterly dividend is $0.53, up from $0.51, and the yield stands at 2.38%. Q2 2026 revenue reached $13.38B (+6.7% YoY), global unit case volume grew 5%, and operating margin expanded to 34.9%. The concentrate model produces enormous free cash flow: management guides FY2026 FCF to ~$12.4B. Shares have rallied 27.82% year to date.
No. 2: Johnson & Johnson, 64 Years and a Healthcare Moat
Johnson & Johnson (NYSE:JNJ) marked its 64th consecutive year of dividend increases with a 3.1% hike to $1.34 quarterly. The yield is 1.96%. Q1 2026 revenue climbed to $24.06B (+9.9% YoY), driven by DARZALEX at $3.96B (+22.5%) and TREMFYA at $1.61B (+68.3%). Management raised FY2026 guidance to revenue of $100.3B-$101.3B and adj EPS of $11.45-$11.65. Pharma demand is inelastic across cycles, which is why the dividend rose through 2008 and 2020 without hesitation. There is some risk worth noting for JNJ: STELARA revenue collapsed 59.7% to $656M on biosimilar competition, and the beta of 0.235 reflects a market that assumes the pipeline will fill the hole.
No. 1: Procter & Gamble, 70 Years of Raises and 136 Years of Payments
Procter & Gamble (NYSE:PG) sits at the top on the metric that matters here: the company just marked its 70th consecutive year of dividend increases and 136th consecutive year of dividend payments, one of the longest streaks in existence. The current quarterly dividend is $1.0885, up from $1.0568, with a yield of 2.99%. FY2026 revenue reached $87.03B (+3.26%) and free cash flow rose to $15.83B (+12.74% YoY). Management plans ~$10B in dividends and ~$5B in buybacks in FY2027. CEO Shailesh Jejurikar called FY2026 “a year of foundation building while continuing to grow sales and profit and return high levels of cash to shareowners despite a very challenging geopolitical and economic environment.”
Committed View
A raise streak that survived four US recessions is a stress test no marketing deck can fake. Procter & Gamble earns the top slot because 70 years of increases and 136 years of continuous payments is the strongest evidence any income investor will find that a payout has been engineered to endure. Johnson & Johnson, Coca-Cola, Colgate-Palmolive and PepsiCo round out a list where the common thread is pricing power on products consumers refuse to give up when times get hard. If the goal is durable income rather than a headline yield, this is the shelf worth looking at (we ranked ten more of these 50-year raisers by valuation in a free Dividend Kings report).
Contact [email protected] for any questions or corrections.
Chris Lange is a financial and geopolitical writer with more than a decade of experience covering a myriad of topics. He has published thousands of articles for 24/7 Wall St., with past coverage focused heavily on stocks, IPOs, healthcare, defense, global affairs, and technology.
His work has been quoted, or referenced by a number of outlets including Business Insider, USA Today, Yahoo Finance, MSN, The Motley Fool, and many other publications. A graduate of Southwestern University, he studied business with a focus on investments and has previous experience in banking and startups.
When not reading or writing the news, he is following his passion for Lacrosse, playing chess, or building solar projects with his dad.
